Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 3 studies | 31% ± 11% | |
smooth muscle cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of LGR6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 1015.27 | 640 / 653 | 69% | 8.58 | 418 / 605 |
ovary | 39% | 275.15 | 71 / 180 | 91% | 51.17 | 391 / 430 |
lung | 83% | 606.37 | 479 / 578 | 43% | 6.43 | 501 / 1155 |
prostate | 87% | 1132.03 | 212 / 245 | 27% | 2.24 | 134 / 502 |
breast | 65% | 955.22 | 297 / 459 | 41% | 8.56 | 463 / 1118 |
bladder | 67% | 504.43 | 14 / 21 | 39% | 7.28 | 198 / 504 |
intestine | 33% | 126.43 | 318 / 966 | 71% | 17.92 | 372 / 527 |
spleen | 100% | 1240.44 | 240 / 241 | 0% | 0 | 0 / 0 |
esophagus | 45% | 485.76 | 657 / 1445 | 54% | 18.15 | 98 / 183 |
blood vessel | 95% | 6986.29 | 1273 / 1335 | 0% | 0 | 0 / 0 |
uterus | 38% | 274.61 | 65 / 170 | 34% | 5.48 | 155 / 459 |
pancreas | 0% | 0.80 | 1 / 328 | 67% | 9.85 | 119 / 178 |
stomach | 8% | 42.45 | 27 / 359 | 59% | 12.90 | 170 / 286 |
skin | 61% | 486.30 | 1109 / 1809 | 2% | 0.28 | 10 / 472 |
brain | 32% | 283.17 | 847 / 2642 | 28% | 8.01 | 195 / 705 |
heart | 58% | 992.07 | 496 / 861 | 0% | 0 | 0 / 0 |
liver | 28% | 116.24 | 63 / 226 | 20% | 2.49 | 81 / 406 |
peripheral blood | 43% | 562.24 | 401 / 929 | 0% | 0 | 0 / 0 |
adipose | 27% | 116.89 | 326 / 1204 | 0% | 0 | 0 / 0 |
kidney | 21% | 92.04 | 19 / 89 | 2% | 0.13 | 16 / 901 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.26 | 9 / 45 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.69 | 4 / 29 |
adrenal gland | 1% | 3.28 | 3 / 258 | 2% | 0.22 | 4 / 230 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
muscle | 1% | 5.37 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990523 | Biological process | bone regeneration |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0008283 | Biological process | cell population proliferation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007411 | Biological process | axon guidance |
GO_0050919 | Biological process | negative chemotaxis |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0016500 | Molecular function | protein-hormone receptor activity |
GO_0008201 | Molecular function | heparin binding |
GO_0048495 | Molecular function | Roundabout binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LGR6 |
Protein name | Leucine-rich repeat-containing G-protein coupled receptor 6 Leucine rich repeat containing G protein-coupled receptor 6 |
Synonyms | UNQ6427/PRO21331 VTS20631 |
Description | FUNCTION: Receptor for R-spondins that potentiates the canonical Wnt signaling pathway and acts as a marker of multipotent stem cells in the epidermis. Upon binding to R-spondins (RSPO1, RSPO2, RSPO3 or RSPO4), associates with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. In contrast to classical G-protein coupled receptors, does not activate heterotrimeric G-proteins to transduce the signal. May act as a tumor suppressor. . |
Accessions | ENST00000439764.2 [Q9HBX8-1] Q5T508 D6R9F0 ENST00000367278.8 [Q9HBX8-3] ENST00000487787.5 ENST00000423542.5 Q9HBX8 ENST00000255432.11 [Q9HBX8-2] |